Despite the smoking stigma associated with lung cancer, one in five lung cancer patients have never smoked.
On average, people diagnosed with lung cancer have less than a one-in-five chance of surviving five years after being diagnosed. With such a significant burden, the need to better understand this disease and find more effective therapies is critical.
Lung Cancer Support
This blood test aims to determine if the patient’s treatment has been effective or whether the cancer has returned, without the need for performing invasive biopsies.
Investigating a newly-discovered chemical compound treatment which has shown promise in inhibiting the growth of lung cancer cells.
Researching the role of cellular 14-3-3 proteins in non-small cell lung cancers (NSCLC), with the aim of finding new treatment options to improve survival rates.